Ex Vivo 1 H NMR study of pituitary adenomas to differentiate various immunohistochemical subtypes

Scientific Reports
Omkar B IjareKumar Pichumani

Abstract

Pituitary adenomas (PAs) are benign growths arising from epithelial cells in the adenohypophysis of the pituitary gland. To date, there has been no detailed metabolic characterization of PAs of various subtypes. In this study, we report nuclear magnetic resonance (NMR) based metabolomic analysis of surgically resected tumors from forty five pituitary tumor patients [gonadotropic (LH/FSH-secreting) = 17; prolactinomas (PRL-secreting) = 11, Cushing's disease (ACTH-secreting) = 4, non-functional = 5, and mixed = 8] who underwent transsphenoidal selective adenomectomy. Compared to LH/FSH-secreting tumors, PRL-secreting tumors showed statistically significant decrease in the levels of N-acetylaspartate (NAA), myo-inositol (mI), scyllo-inositol (sI), glycine, taurine, phosphoethanolamine (PE) and increase in the levels of glutamine. When compared with LH/FSH-secreting tumors, ACTH-secreting tumors showed statistically significant decrease in the levels of sI, glycine, PE and increase in the levels of aspartate. Although lipid extracts of PAs showed the presence of many common lipid molecules, only glycerophosphoethanolamine (GPE) showed statistically significant decrease in PRL, ACTH and non-functional subtypes when compared to LH/FS...Continue Reading

References

Nov 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·T Kano-SueokaH Fujiki
Nov 1, 1981·Experimental Cell Research·T Kano-Sueoka, J E Errick
Jan 1, 1980·Virchows Archiv. A, Pathological Anatomy and Histology·K KovacsC Ezrin
Feb 1, 1996·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·R K TyagiY Salomon
Jun 22, 2000·NMR in Biomedicine·V GovindarajuA A Maudsley
Dec 9, 2003·The Journal of Clinical Investigation·Shlomo Melmed
Feb 6, 2007·Progress in Neurobiology·John R MoffettAryan M A Namboodiri
Aug 2, 2008·Journal of Neurosurgery·Andreas StadlbauerOliver Ganslandt
Oct 1, 2008·Journal of Neuro-oncology·Mikhail F ChernovKintomo Takakura
Mar 18, 2010·NMR in Biomedicine·Hongxia LeiRolf Gruetter
Jan 21, 2016·Proceedings of the National Academy of Sciences of the United States of America·Alan K JarmuschR Graham Cooks
Jul 11, 2016·Neurochemical Research·Ana I AmaralUrsula Sonnewald

❮ Previous
Next ❯

Methods Mentioned

BETA
NMR

Software Mentioned

TopSpin
Bruker

Related Concepts

Related Feeds

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.